Insider · CIK 0001867418

Barton Russell

Reports to the SEC for 1 company · NEWTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001867418

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-22	ABOSAcumen Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−462 sh	$1.84	−$850.08	205,092
2026-01-21	ABOSAcumen Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−2,315 sh	$1.81	−$4,180.89	205,554
2026-01-16	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+127K sh	—	—	126,900
2026-01-16	ABOSAcumen Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+84.6K sh	—	—	207,869
2026-01-08	ABOSAcumen Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−3,530 sh	$1.86	−$6,561.564	123,269
2026-01-07	ABOSAcumen Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−1,700 sh	$1.99	−$3,378.07	126,799
2026-01-06	ABOSAcumen Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−3,618 sh	$1.97	−$7,114.435	128,499
2026-01-05	ABOSAcumen Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−4,000 sh	$1.96	−$7,832.4	132,117
2025-01-21	ABOSAcumen Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−2,914 sh	$1.61	−$4,692.123	136,117
2025-01-06	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+74.7K sh	—	—	74,700
2025-01-06	ABOSAcumen Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+49.8K sh	—	—	139,031
2025-01-03	ABOSAcumen Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−7,636 sh	$1.86	−$14.2K	89,231
2024-01-18	ABOSAcumen Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−2,833 sh	$3.73	−$10.6K	96,867
2024-01-02	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+110K sh	—	—	110,000
2024-01-02	ABOSAcumen Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+73K sh	—	—	99,700
2023-01-17	ABOSAcumen Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+26.7K sh	—	—	26,700
2023-01-17	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+120K sh	—	—	120,200
2022-01-19	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+135K sh	—	—	135,000

Recent filings

Accepted (ET)
Jan 234
Barton Russell0001628280-26-003344
SEC(opens sec.gov)
Jan 214
Barton Russell0001628280-26-002958
SEC(opens sec.gov)
Jan 124
Barton Russell0001628280-26-001897
SEC(opens sec.gov)
Jan 74
Barton Russell0001628280-26-001261
SEC(opens sec.gov)
Jan 234
Barton Russell0001576885-25-000031
SEC(opens sec.gov)
Jan 74
Barton Russell0001576885-25-000013
SEC(opens sec.gov)
Jan 194
Barton Russell0001576885-24-000024
SEC(opens sec.gov)
Jan 44
Barton Russell0001576885-24-000013
SEC(opens sec.gov)
Jan 184
Barton Russell0001209191-23-003731
SEC(opens sec.gov)
Jan 214
Barton Russell0001209191-22-004415
SEC(opens sec.gov)

Companies

Acumen Pharmaceuticals, Inc.Chief Operating OfficerABOS

Address

C/O ACUMEN PHARMACEUTICALS, INC. 1210-1220 WASHINGTON STREET, SUITE 210

NEWTON, MA, 02465